BIOCOM for BIOCOM
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Expressed support for the Bayh-Dole Act, as part of the law's 40th anniversary campaign. Expressed concerns about the misuse of "march-in rights" and compulsory licenses. Expressed support for PTAB protections.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Budget/Appropriations BUD
Advocated for additional funding for NIH, FDA, CDC and BARDA in FY2021 appropriations and coronavirus supplemental legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Sent information to House and Senate staff about the life science's industry response to covid-19 Expressed strong concerns about executive orders and rules on most-favored nation and importation Hosted a legislative roundtable with Rep. Scott Peters Hosted a legislative roundtable with Rep. Harley Rouda Hosted a legislative roundtable with Rep. Ami Bera Expressed support for the coverage of home infusion of Medicare Part B drugs during the covid-19 pandemic. Expressed our position on domesticating the US drug supply chain Expressed our position on value-based agreements, line extensions and copay accumulator programs Expressed support for expanding telehealth services Expressed support for policies that encourage the use and development of novel antibiotics to fight anti-microbial resistance (AMR)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.